NCT03344211: Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 30 taking part
- Started
- 21 Nov 2018
- Primary completion
- 31 Dec 2026
- Arms
- Arm I (enzalutamide, radium 223)
- Results
- None posted
- 17 Nov 2017: Trial registered
- 21 Nov 2018: Trial started